DNCG ISO: A Comprehensive Overview

Introduction

DNCG ISO, a sterile inhalation solution, is an effective treatment for preventing asthmatic symptoms in individuals with allergic and non-allergic asthma.

This solution contains sodium cromoglicate, a medication that helps to stabilize mast cells, the immune cells that release histamine and other inflammatory mediators. By inhibiting the release of these substances, DNCG ISO can effectively reduce airway inflammation and prevent the development of asthmatic symptoms.

Indications

DNCG ISO is indicated for the prevention of asthmatic symptoms in patients with mild persistent asthma, including those with allergic and non-allergic asthma.

Dosage and Administration

DNCG ISO is administered via inhalation using a nebulizer. The recommended dosage and frequency of administration depend on the individual patient's needs and should be determined by a healthcare professional.

Side Effects

As with all medications, DNCG ISO may cause side effects, although these are generally mild. Common side effects include:

• Cough
• Hoarseness
• Throat irritation
• Nausea
• Headache
• Asthmatic symptoms may worsen in a few patients

If any of these side effects occur, it is important to inform your healthcare provider.

Conclusion

DNCG ISO is a safe and effective treatment for preventing asthmatic symptoms in patients with mild persistent asthma. It is important to use this medication as prescribed by your healthcare provider to achieve optimal results.